Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 19, 2023

SELL
$37.58 - $52.57 $28,185 - $39,427
-750 Reduced 74.26%
260 $11,000
Q1 2022

Apr 26, 2022

SELL
$76.85 - $89.45 $5,763 - $6,708
-75 Reduced 6.91%
1,010 $78,000
Q2 2021

Jul 29, 2021

SELL
$80.5 - $88.01 $4,830 - $5,280
-60 Reduced 5.24%
1,085 $87,000
Q2 2020

Jul 31, 2020

SELL
$78.66 - $94.14 $246,599 - $295,128
-3,135 Reduced 73.25%
1,145 $99,000
Q1 2020

May 06, 2020

SELL
$71.57 - $93.3 $15,745 - $20,526
-220 Reduced 4.89%
4,280 $347,000
Q3 2019

Oct 17, 2019

SELL
$81.4 - $89.78 $44,770 - $49,379
-550 Reduced 10.89%
4,500 $394,000
Q3 2018

Oct 22, 2018

SELL
$70.71 - $77.75 $707 - $777
-10 Reduced 0.2%
5,050 $389,000
Q4 2017

Jan 11, 2018

BUY
$61.45 - $66.05 $310,937 - $334,213
5,060
5,060 $327,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Sawyer & Company, Inc Portfolio

Follow Sawyer & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sawyer & Company, Inc with notifications on news.